INS and metabolic dysfunction-associated steatotic liver disease: Insulin resistance, defined as reduced insulin sensitivity and detected in approximately 40% of patients with NAFLD [67], arises from the reduced expression of insulin receptors, ineffective insulin-receptor bindings, or impairment in insulin signaling [66,68].